secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2022-06-24T23:59:59+00:00
Accession:  0001104659-22-074363
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------------------

- Received Nasdaq letter on June 22, 2022 for bid price <$1.00 over 30 consecutive business days ended June 21, 2022.
- Company has 180-day compliance period until December 19, 2022 to regain compliance by closing at $1.00 for 10 consecutive business days.
- If not compliant by Dec 19, may qualify for additional 180 days by meeting all other listing standards and effecting reverse stock split if necessary.
- No immediate impact on listing; common stock continues trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465922074363/0001104659-22-074363-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465922074363/tm2219233d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-074363

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer